Sapphiros Funding & Investors
Boston, MA
Sapphiros invests in growth-stage diagnostic companies, focusing on technologies that prioritize innovation and patient-centric approaches. The company possesses a portfolio of capabilities and technologies encompassing innovative sample collection, next-generation diagnostics, computational biology, and printed electronics. These elements contribute to the global accessibility of crucial diagnostic results for consumers.
sapphiros.comTotal Amount Raised: $41,000,000
Sapphiros Funding Rounds
Series B
$30,000,000
Series B Investors
OraSure TechnologiesGrant
$11,000,000
Grant Investors
National Institutes of Health (NIH)
Funding info provided by Diffbot.